Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Consider benefits and risks of new alopecia treatments for safety.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Finasteride effectively treats male hair loss, increasing length and thickness.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

More research is needed to find effective treatments for sickle cell disease-related priapism.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Urologic diseases and treatments in older men can negatively affect fertility, and doctors should talk to patients about this.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Finasteride improves hair loss in women with hyperandrogenism.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Oral minoxidil is effective for various hair loss types and may improve male sexual function, but aspirin can reduce its effectiveness.